首页> 美国卫生研究院文献>Pharmaceutics >Self-Emulsifying Granules and Pellets: Composition and Formation Mechanisms for Instant or Controlled Release
【2h】

Self-Emulsifying Granules and Pellets: Composition and Formation Mechanisms for Instant or Controlled Release

机译:自乳化颗粒和丸剂:即时或控制释放的组成和形成机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Many articles have been published in the last two decades demonstrating improvement in the dissolution and absorption of low solubility drugs when formulated into self-emulsifying drug delivery systems (SEDDS). Several such pharmaceutical products have appeared in the market for medium dose (Neoral® for Cyclsoprin A, Kaletra® for Lopinavir and Ritonavir), or low dose medications (Rocaltrol® for Calcitriol and Avodart® for Dutasteride). However, these are in the form of viscous liquids or semisolid presentations, characterized by the disadvantages of high production cost, stability problems and the requirement of large quantities of surfactants. Solid SEDDS (S-SEDDS), as coarse powders, granules or pellets, besides solubility improvement, can be filled easily into capsules or processed into tablets providing a handy dosage form with instant release, which can be further developed into controlled release by mixing with suitable polymers or coating with polymeric films. In this review, the materials used for the preparation of S-SEDDS, their properties and role in the formulations are detailed. Factors affecting the physical characteristics, mechanical properties of S-SEDDS as well as their in vitro release and in vivo absorption are discussed. The mechanisms involved in the formation of instant and sustained release self-emulsifying granules or pellets are elucidated. Relationships are demonstrated between the characteristics of S-SEDDS units (size, shape, mechanical properties, re-emulsification ability, drug migration and drug release) and the properties of the submicron emulsions used as massing liquids, with the aim to further elucidate the formation mechanisms. The influence of the composition of the powdered ingredients forming the granule or pellet on the properties of S-SEDDS is also examined. Examples of formulations of S-SEDDS that have been reported in the literature in the last thirteen years (2004–2017) are presented.
机译:在过去的二十年中,已经发表了许多文章,证明了将低溶解度药物配制成自乳化药物递送系统(SEDDS)时,其溶解和吸收得到了改善。几种这样的药品已经出现在市场上,其中中等剂量(用于环孢菌素A的Neoral ®,洛匹那韦和利托那韦的Kaletra ®)或低剂量药物(Rocaltrol ®(用于骨化三醇)和Avodart ®(用于度他雄胺)。然而,它们以粘性液体或半固体形式存在,其特征在于高生产成本,稳定性问题和需要大量表面活性剂的缺点。固体SEDDS(S-SEDDS),除了粗粉,颗粒或小丸,除了改善溶解度外,还可以轻松装入胶囊或加工成片剂,提供方便的剂型,具有速释性,可通过与以下物质混合进一步发展为控释性合适的聚合物或聚合物膜涂层。在这篇综述中,详细介绍了用于制备S-SEDDS的材料,它们的性质和在配方中的作用。讨论了影响S-SEDDS物理特性,机械性能以及其体外释放和体内吸收的因素。阐明了形成速释和持续释放自乳化颗粒或小球的机理。证明了S-SEDDS单元的特性(尺寸,形状,机械性能,再乳化能力,药物迁移和药物释放)与用作集装液体的亚微米乳液的特性之间的关系,目的是进一步阐明其形成。机制。还检查了形成颗粒或丸粒的粉状成分的组成对S-SEDDS的性能的影响。介绍了过去十三年(2004-2017年)文献中报道的S-SEDDS制剂实例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号